MARKET

SEMHF

SEMHF

Siemens Healthineers Ag
OTCPK

Real-time Quotes | Nasdaq Last Sale

55.45
-2.70
-4.64%
Opening 09:30 05/17 EDT
OPEN
--
PREV CLOSE
55.45
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
77.09
52 WEEK LOW
55.45
MARKET CAP
55.45B
P/E (TTM)
30.89
1D
5D
1M
3M
1Y
5Y
Siemens Healthineers AG Non-GAAP EPS of $0.67, revenue of $5.46B misses by $20M
Siemens Healthineers AG (OTCPK:SEMHF): Q2 Non-GAAP EPS of $0.67. Revenue of $5.46B (+37.9% Y/Y) misses by $20M. Press release
Seekingalpha · 05/04 12:58
BRIEF-Siemens Healthineers And Cerebriu Establish R&D Partnership
reuters.com · 03/09 12:34
Smith & Nephew appoints former Siemens Healthineers exec as CEO
Smith & Nephew (NYSE:SNN) appointed Deepak Nath as CEO, effective  April 1, succeeding Roland Diggelmann, who will step down by mutual agreement on March 31. Nath joins Smith+Nephew from Siemens Healthineers (OTCPK:SEMHF) (OTCPK:SMMNY) where
Seekingalpha · 02/22 10:09
Smith+Nephew names new CEO, narrowly misses on annual profit
reuters.com · 02/22 07:18
Siemens Healthineers AG Non-GAAP EPS of €0.55, revenue of €5.07B
Siemens Healthineers AG press release (OTCPK:SEMHF): FQ1 Non-GAAP EPS of €0.55. Revenue of €5.07B (+31.3% Y/Y).
Seekingalpha · 02/03 14:28
Millions of Siemens Healthineers CLINITEST Rapid COVID-19 Antigen Self-Test Now Available in the U.S.
TARRYTOWN, N.Y., February 03, 2022--Siemens Healthineers announced today the CLINITEST® Rapid COVID-19 Antigen Self-Test1,2 is now available in the U.S. to self-test for the SARS-CoV-2 virus. The CLINITEST Rapid COVID-19 Antigen Self-Test uses a simple nas...
Business Wire · 02/03 10:08
MORNING BID-Walk on the wild side
reuters.com · 01/31 07:39
German stocks - Factors to watch on January 21
reuters.com · 01/21 05:47
More
No Data
Learn about the latest financial forecast of SEMHF. Analyze the recent business situations of Siemens Healthineers Ag through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 25 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

24.00%Strong Buy
52.00%Buy
24.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SEMHF stock price target is 71.47 with a high estimate of 79.29 and a low estimate of 61.55.
High79.29
Average71.47
Low61.55
Current 55.45
EPS
Actual
Estimate
0.170.330.490.66
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 0
Institutional Holdings: 0
% Owned: 0.00%
Shares Outstanding: 1.00B
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
1
7.30M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data
About SEMHF
Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company is developing its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare to enable healthcare providers to increase value. Siemens AG is a majority shareholder of the Company. The Company is active worldwide.

Webull offers kinds of Siemens Healthineers AG stock information, including OTCPK:SEMHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEMHF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SEMHF stock methods without spending real money on the virtual paper trading platform.